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Abstract
Clustered Regularly Interspaced Short Palindromic Repeats
(CRISPR) is an exciting new genetic engineering technology that
was found in the chromosomes of certain bacteria and archaea.
Bacteriophage are viruses that insert their DNA and hijack the
host cell’s machinery to make new phage that can go on to
infect new cells. Some microorganisms use CRISPR as a defense
mechanism to disrupt the bacteriophage DNA after it is
inserted into the cell. CRISPR/Cas9 uses genome editing as a
means to alter very specific sections of a foreign genome.
CRISPR works with a RNA-guided DNA endonuclease called
Cas9. This enzyme can locate and cut viral DNA and inactivate it
so that it cannot replicate. Cas9 elicits the help of two forms of
RNA called tracrRNA and gRNA (guide). These RNAs work with
Cas9 to make modifications within the viral DNA. The
CRISPR/Cas9 system is a genetic discovery that will aid
researchers in the ability to target viral genomes and edit them.
This technique may be able to clear latently infected cells as
well as prevent new infections.
• Infectious diseases are a leading cause of death
worldwide. Novel therapeutics are urgently required to
treat multidrug-resistant organisms such as
Mycobacterium tuberculosis and to mitigate morbidity
and mortality caused by acute infections such as
malaria and dengue fever virus as well as chronic
infections such as human immunodeficiency virus-1 and
hepatitis B virus. (1)
• The recent development of the clustered regularly
interspaced short palindromic repeats (CRISPR)/CRISPRassociated protein 9 (Cas9) system as a genome-editing
technique has significantly facilitated gene
modifications in both pathogen and host cells and
enables profound analysis of the molecular mechanisms
that are involved in pathogenesis of infection. (2)

Figure 1. How CRISPR/Cas9 finds and locates target DNA for cleavage and repair
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Applications for CRISPR/Cas9
• CRISPR is being used to target latent HIV-1 provirus.
• When LTR-targeting CRISPR/Cas9 components were
transfected into HIV-1 LTR expression-dormant and inducible T cells, a significant loss of LTR-driven
expression was observed after stimulation.
Sequence analysis confirmed that this CRISPR/Cas9
system efficiently cleaved and mutated LTR target
sites. More importantly, this system was also able to
remove internal viral genes from the host cell
chromosome. Results suggest that the CRISPR/Cas9
system may be a useful tool for curing HIV-1
infection. (3)

Figure 3. Computer animated artistic rendition of the CRISPR/Cas9 Gene
editing system.

Discussion

Figure 2. HIV-1 genome editing effects using LTR-targeted CRISPR/Cas9 System

• Researchers tested different HBV-specific guide RNAs
and demonstrated that they could inhibit HBV infections
up to eightfold. Inhibition was due to mutations and
deletions in cccDNA similar to those observed with
chromosomal DNA cleaved by Cas9 and repaired by
non-homologous end joining (NHEJ). Interferon alpha
(IFN-α) did not have a measurable effect on the antiviral
activity of the CRISPR/Cas9 system, suggesting that Cas9
and NHEJ activities are not affected by induction of an
innate immune response with the cytokine.(4)

• The discovery of the CRIPSR/CAS9 system has
simplified the approach for current genome
editing techniques.
• CRISPR/Cas9 is revolutionizing the way that we
are utilizing genetic engineering as a means to
prevent and cure infectious disease.
• CRISPR/Cas9 is a promising genetic tool that
may help facilitate a cure for chronic
autoimmune disorders.
• CRISPR/Cas9 system has great potential in the
development of novel antimicrobials and
vaccines and therefore has the ability to open
new avenues both for treatment and
prevention of infectious diseases. (5)

Figure 4. Ribbon Model of CRISPR/Cas9 Complex
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